Journal
CANCER TREATMENT REVIEWS
Volume 32, Issue 7, Pages 557-571Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2006.07.005
Keywords
metastatic colorectal cancer; chemotherapy; review
Categories
Ask authors/readers for more resources
Metastatic colorectal cancer remains a pubtic-health issue on a global scale. With development of a new generation of cytotoxic agents, survival has improved for patients with metastatic disease. How to maximize the benefit of chemotherapy with acceptable toxicity remains uncompletely answered. Hepatic resection can provide a significant hope for tong term survival, and a subset of patients might benefit from perioperative approaches. More recently, specific molecular processes have been targeted for therapeutic interventions, and encouraging results have been achieved using inhibitors of the Epidermal Growth Factor Receptor and the Vascular Endothelial Growth Factor. (c) 2006 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available